Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination.

Aydin, Mehmet Fethullah; Yildiz, Abdülmecit; Oruç, Aysegül; Sezen, Mehmet; Dilek, Kamil; Güllülü, Mustafa; Yavuz, Mahmut; Ersoy, Alparslan

Aydin, Mehmet Fethullah; Yildiz, Abdülmecit; Oruç, Aysegül; Sezen, Mehmet; Dilek, Kamil; Güllülü, Mustafa; Yavuz, Mahmut; Ersoy, Alparslan.

Aydin MF; Division of Nephrology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey. Electronic address: mfaydin@uludag.edu.tr.
Yildiz A; Division of Nephrology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.
Oruç A; Division of Nephrology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.
Sezen M; Division of Nephrology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.
Dilek K; Division of Nephrology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.
Güllülü M; Division of Nephrology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.
Yavuz M; Division of Nephrology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.
Ersoy A; Division of Nephrology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.

Kidney Int ; 100(2): 464-465, 2021 08.

Article in English | MEDLINE | ID: covidwho-1228097

Subject(s)

COVID-19 Vaccines/adverse effects; COVID-19; Glomerulonephritis, Membranous; Aged; COVID-19/prevention & control; Female; Humans; Recurrence; Vaccination; Vaccines, Inactivated/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Glomerulonephritis, Membranous / COVID-19 Vaccines / COVID-19 Type of study: Case report Topics: Vaccines Limits: Aged / Female / Humans Language: English Journal: Kidney Int Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google